68Ga-DOTA-HTA-DM

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Name68Ga-DOTA-HTA-DM

Drug Alias Name68Ga-DOTA-HTA-DM

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide Radionuclide ConjugateRadiation-emitting products > Peptide Radionuclide Conjugate +[4]

Mechanisms of ActionNectin-4 binders

TargetsNectin-4

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHta Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHta Co Ltd

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A